Acasti Pharma Inc. (NASDAQ: ACST) Stock Information | RedChip

Acasti Pharma Inc. (NASDAQ: ACST) Listen to this Section


$2.42
N/A ( 0% ) 11.0K

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.

Market Data


Open


$2.42

Previous close


$2.42

Volume


11.0K

Market cap


$25.35M

Day range


$2.37 - $2.53

52 week range


$1.72 - $3.59

Insider Ownership Transactions

Total Amount Purchased: -317,298.00 | $ -767,861.16

Date Type Amount Purchased Purchaser
2024-05-08 Sale -128770.00 Kohli Prashant
2024-05-08 Sale -19740.00 D'Andrea Carrie
2024-05-08 Sale -19740.00 Kumar Amresh
2024-05-08 Sale -25380.00 Macdonald R. Loch
2024-05-08 Sale -4500.00 DelAversano Robert J
2023-12-20 Sale -41668.00 Kohli Prashant
2023-12-20 Sale -10000.00 Kavuru Vimal
2023-12-20 Sale -22500.00 Kottayil George
2023-12-20 Sale -22500.00 NEUGEBOREN EDWARD
2023-12-20 Sale -22500.00 DAVIS A BRIAN

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Aug 09, 2024
10-q Quarterly Reports 70 Aug 09, 2024
3/a Insider transactions 1 Jul 11, 2024
3 Insider transactions 1 Jul 09, 2024
8-k 8K-related 13 Jun 27, 2024
8-k 8K-related 13 Jun 21, 2024
10-k Annual reports 96 Jun 21, 2024
4/a Other 1 May 10, 2024
4/a Other 1 May 10, 2024
4 Insider transactions 1 May 08, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.